Clinical and commercial fill-finish capabilities for pre-filled syringes are being established at one of the Aesica production sites. Aesica has...

Bespak and Aesica to jointly develop a ready-to-use nasal delivered version of nalmefene to treat opioid overdoses  Consort Medical plc (LSE...

With a counterfeit drug market now estimated at $200bn, many countries are putting serialisation legislation in place.In this three part webinar...

July 2016: Aesica Pharmaceuticals, the global pharmaceutical contract development and manufacturing organisation (CDMO) is pleased to release their...